SGLT2 territory. 3 years. still a coin flip.

Company: Boehringer Ingelheim

Posted by JardianceRep_BI_Midwest_4459 · March 17, 2026

Tags: field, strategy, quota

cant out-data AZ because they have equivalent outcomes data.

cant out-price because its formulary.

only lever is showing up more than them.

EMPEROR-Reduced in HFrEF is where I find any separation.

granular beats broad every time.

13 upvotes · 5 comments